We’re Celebrating a Milestone Year
2025 marks 30 years of The American Journal of Managed Care®. To commemorate this milestone, we’re sharing even more valuable content, from exclusive interviews and insights from thought leaders to facts and figures on our 3 decades of impact.
ACS’ Dahut on Finding Cancer Before It Starts, and Funding Researchers as They Start
Abortion Bans Linked to Higher Infant Mortality, Disproportionately Impact Black Infants
Systemic Solutions to Improve Telehealth Access for Non-English Speakers
Despite Increases, Gender Disparities in Life Expectancy Persist Among People With HIV
Skills to Enhance the Patient-Provider Relationship in Complex Care Settings
Advancing Integrated Care for Comorbid Schizophrenia and Substance Use Disorder
Abstracts Highlight Access Barriers, CV Risks Associated With IBD Care
Rising Breast Cancer Rates Show Disparities Across Racial, Ethnic Groups in the US
Academic Cancer Centers See Longer Survival in CLL, MCL Than Community Centers
Decline in Psychiatrists Billing Medicare Part B Sparks Mental Health Access Concerns
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Final Thoughts on Bispecifics in B-Cell Lymphomas From ASH 2024
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
MCL Therapy Selection and Sequencing
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Advancing Hematologic Care and the Future of Shared Decision-Making
Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer
TROPION-Breast01: Datopotamab Deruxtecan Improves Progression-Free Survival
Receiving NADT for 6 Months Doesn’t Impact Outcomes in Intermediate-Risk Prostate Cancer After EBRT
The Case for HS Centers of Excellence: Evidence for Improved Patient Outcomes
Bridging the Gap: Enhancing Communication on Bispecifics Between Academic and Community Centers
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Reflections on 2024’s Progress in R/R CLL
Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer
Receiving NADT for 6 Months Doesn’t Impact Outcomes in Intermediate-Risk Prostate Cancer After EBRT
ACS’ Dahut on Finding Cancer Before It Starts, and Funding Researchers as They Start
The Impact of ADT for Prostate Cancer on Survival and Patient Well-Being
KAP Regarding ChatGPT Among Health Care Professionals: Correspondence
Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans
Hospitalization Patterns Among Older Patients With Cancer With and Without Dementia
MRD and Other Predictors From FELIX for Obe-Cel Success in R/R B-ALL
Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment Duration
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
Spotlight on Access and Equity: Bispecifics for Multiple Myeloma in the Community Setting
SPOTLIGHT: Cilta-Cel Shows Sustained MRD Negativity; Leads to Prolonged PFS in Multiple Myeloma
The High Cost of Shortages of Low-Cost Chemotherapy
Challenges in Treatment of Desmoid Tumors and Managed Care Solutions
Desmoid Tumors: What Managed Care Professionals Need to Know to Manage These Unpredictable Tumors, featuring a Pharmacy Focus Podcast
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Novel Therapies and Emerging Strategies for HR+/HER2- Metastatic Breast Cancer and the Impact on Patient Outcomes
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know
Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes
Novel Agents as Proactive Approaches to Addressing Food Allergy: The Role of the Pharmacist in Guiding Optimal Treatment
